Cancer

News

AZ/Daiichi Sankyo's partnership makes progress in lung cance...

AstraZeneca and Daiichi Sankyo have announced data from two drugs in lung cancer, which they are developing as part of their ongoing partnership.

News

Doctors warn pandemic has pushed lung cancer services back 2...

Governments must act to restore the damage done to lung cancer services during the pandemic in order to reduce further avoidable deaths, according to a report drawn up as part of this week'

News

Careology joins forces with remote care support firm RedArc

Digital cancer care platform Careology has joined forces with RedArc, which provides long-term support for people with serious illnesses.

News

AZ/Daiichi Sankyo's Enhertu gets second US cancer indication

AstraZeneca and Daiichi Sankyo’s Enhertu cancer drug has picked up a second indication, in patients who have stomach cancer and haven’t responded to Roche’s Herceptin (trastuzumab).

News

Ex-Merck & Co scientist accused of stealing trade secrets co...

A former Merck & Co scientist could face up to 10 years in prison after he was accused of stealing trade secrets relating to drugs including the cancer immunotherapy Keytruda by US auth

News

NICE recommends interim funding for GSK's Zejula in ovarian ...

Women with newly-diagnosed advanced ovarian cancer have a new treatment option in England after NICE recommend interim funding for GlaxoSmithKline’s Zejula (niraparib) in final guidance.

AZ/Daiichi Sankyo's partnership makes progress in lung cance...

Doctors warn pandemic has pushed lung cancer services back 2...

Careology joins forces with remote care support firm RedArc

AZ/Daiichi Sankyo's Enhertu gets second US cancer indication

Ex-Merck & Co scientist accused of stealing trade secrets co...

NICE recommends interim funding for GSK's Zejula in ovarian ...

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

Cancer

Editor's Picks